Skip to main content

The Role of Drug-Coated Balloons on Late Lumen Enlargement

  • Chapter
  • First Online:
Drug-Coated Balloons

Abstract

Late lumen enlargement (LLE) is an increase of the luminal size of a coronary artery following angioplasty, compared to the immediate post intervention luminal size. We discuss the possible contributory factors here specially focusing on late lumen enlargement seen after drug coated balloon (DCB) - only angioplasty.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Park JJ, Chae IH, Cho YS, et al. The recanalization of chronic total occlusion leads to lumen area increase in distal reference segments in selected patients: an intravascular ultrasound study. JACC Cardiovasc Interv. 2012;5:827–36.

    Article  Google Scholar 

  2. Galassi AR, Tomasello SD, Crea F, et al. Transient impairment of vasomotion function after successful chronic total occlusion recanalization. J Am Coll Cardiol. 2012;59:711–8.

    Article  Google Scholar 

  3. Johnson MR, Brayden GP, Ericksen EE, et al. Changes in cross-sectional area of the coronary lumen in the six months after angioplasty: a quantitative analysis of the variable response to percutaneous transluminal angioplasty. Circulation. 1986;73:467–75.

    Article  CAS  Google Scholar 

  4. Cappelletti A, Margonato A, Rosano G, et al. Short- and long-term evolution of unstented nonocclusive coronary dissection after coronary angioplasty. J Am Coll Cardiol. 1999;34:1484–8.

    Article  CAS  Google Scholar 

  5. Leimgruber PP, Roubin GS, Anderson HV, et al. Influence of intimal dissection on restenosis after successful coronary angioplasty. Circulation. 1985;72:530–5.

    Article  CAS  Google Scholar 

  6. Cortese B, Silva Orrego P, Agostoni P, et al. Effect of drug-coated balloons in native coronary artery disease left with a dissection. JACC Cardiovasc Interv. 2015;8:2003–9.

    Article  Google Scholar 

  7. Block PC. Percutaneous transluminal coronary angioplasty. Am J Roentgenol. 1980;135:955–9.

    Article  CAS  Google Scholar 

  8. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113:414–9.

    Article  CAS  Google Scholar 

  9. Karalis I, Ahmed TAHN, Jukema JW. Late acquired stent malapposition: why, when and how to handle? Heart. 2012;98:1529–36.

    Article  Google Scholar 

  10. Togni M, Windecker S, Cocchia R, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol. 2005;46:231–6.

    Article  CAS  Google Scholar 

  11. Kleber FX, Schulz A, Waliszewski M, et al. Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty. Clin Res Cardiol. 2015;104:217–25.

    Article  CAS  Google Scholar 

  12. Speck U, Cremers B, Kelsch B, et al. Do pharmacokinetics explain persistent restenosis inhibition by a single dose of paclitaxel? Circ Cardiovasc Interv. 2012;5:392–400.

    Article  CAS  Google Scholar 

  13. Axel DI, Kunert W, Goggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636–45.

    Article  CAS  Google Scholar 

  14. Pires NM, Eefting D, de Vries MR, et al. Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries. Heart. 2007;93:922–7.

    Article  CAS  Google Scholar 

  15. Ann SH, Balbir Singh G, Lim KH, et al. Anatomical and physiological changes after paclitaxel-coated balloon for atherosclerotic De novo coronary lesions: serial IVUS-VH and FFR study. PLoS One. 2016;11:e0147057.

    Article  Google Scholar 

  16. Gray WA, Granada JF. Drug-coated balloons for the prevention of vascular restenosis. Circulation. 2010;121:2672–80.

    Article  Google Scholar 

  17. Her AY, Ann SH, Singh GB, et al. Serial morphological changes of side-branch ostium after paclitaxel-coated balloon treatment of De novo coronary lesions of main vessels. Yonsei Med J. 2016;57:606–13.

    Article  CAS  Google Scholar 

  18. Levin AD, Vukmirovic N, Hwang CW, et al. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci U S A. 2004;101:9463–7.

    Article  CAS  Google Scholar 

  19. Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371–5.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. C. Eccleshall .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wickramarachchi, U., Eccleshall, S.C. (2019). The Role of Drug-Coated Balloons on Late Lumen Enlargement. In: Cortese, B. (eds) Drug-Coated Balloons . Springer, Cham. https://doi.org/10.1007/978-3-319-92600-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-92600-1_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-92599-8

  • Online ISBN: 978-3-319-92600-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics